Northwestern Medicine First in Illinois to Use New Mitral Valve Replacement Device
A Northwestern Memorial Hospital patient was the first in Illinois to receive a newly approved device to repair a leaky mitral valve without undergoing open-heart surgery.
Mark Ricciardi, MD, director of cardiac catheterization and interventional cardiology at Northwestern Memorial Hospital, led the procedure to repair the leaky mitral valve with the MitraClip NT, a new version of an established device. The MitraClip NT is placed onto the patient’s mitral valve through a blood vessel in the leg, avoiding the risks of open-heart surgery and the significant in-hospital recovery time that follows.
“At Northwestern, we are proud to be leaders in Illinois and beyond in transcatheter heart therapies, procedures like this one that restore quality of life and can add years as well,” said Dr. Ricciardi, who is also an associate professor of medicine – cardiology at Northwestern University Feinberg School of Medicine. “We are always looking to match the best treatment with the patient and this new device allows us to do that for a select group who would be unable to withstand traditional valve surgery.”
The procedure is for patients who are poor candidates for open heart surgery for mitral regurgitation, a life-threatening condition where blood flows backward into the mitral valve every time the heart contracts. Mild regurgitation can be treated with medication but more severe cases may require surgery to replace or repair the mitral valve.
Northwestern Medicine’s Bluhm Cardiovascular Institute is one of the top 10 national programs for cardiology and heart surgery, according to U.S. News and World Report, and consistently ranked the top cardiovascular program in Chicago, Illinois and the surrounding states. Learn more about Northwestern Medicine’s top ranked cardiovascular care by calling 312.NM.HEART.